Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07053111 · ClinicalTrials.gov registry record · NA
The Counselor Led Resident Wellness Study
A NA study of Anxiety and Burnout, Healthcare Workers, sponsored by University of Nevada, Reno.
- Active
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT07053111: Active NA study of Anxiety and Burnout, Healthcare Workers, sponsored by University of Nevada, Reno.
NCT07053111 is a NA study of Anxiety and Burnout, Healthcare Workers that is active but no longer recruiting, run by University of Nevada, Reno. The registered enrollment target is 21 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07053111, a NA study of Anxiety and Burnout, Healthcare Workers, is active but no longer recruiting, sponsored by University of Nevada, Reno.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Residency is a challenging time in a physician's career. The investigators hope this study will provide a new wellness support model for residency programs to use for resident physicians. The purpose of this study is to examine the impact of a wellness support model for residency programs that is lead by licensed counselors. The investigators expect that participating resident physicians will feel and perform better in their job and your life with this additional support.
Primary Outcome
The WHO-5 is a self-report instrument measuring mental well-being. It consists of five statements relating to the past two weeks. Each statement is rated on a 6-point scale, with higher scores indicating better mental well-being. Specifically, a score of 0 indicates the participant taking the survey has "At no time" experienced the statement in question, while a score of 5 indicates the participant experiences the statement "All of the time." A gradient of numbers in between 0-5 represents incre
Conditions Studied
Interventions
- BEHAVIORAL Wellness Intervention
Study Locations (1)
Nevada
- University Health Internal Medicine Clinic - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT07053111 still lists
NCT07053111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Wellness Intervention is the first listed.
NCT07053111 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT07053111 about?
NCT07053111 is a clinical study titled "The Counselor Led Resident Wellness Study". Residency is a challenging time in a physician's career. The investigators hope this study will provide a new wellness support model for residency programs to use for resident physicians. The purpose of this study is to examine the impact of a wellness support model for residency programs that is le...
What is the current status of trial NCT07053111?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2025-07-11. Estimated completion is 2026-06.
What conditions does trial NCT07053111 study?
This clinical trial studies the following conditions: Anxiety, Burnout, Healthcare Workers, Depression Not Otherwise Specified, Wellness Program.
What interventions are being tested in trial NCT07053111?
The interventions under investigation include: Wellness Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07053111?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07053111 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07053111's enrollment target sits among peer trials
21 323rd of 364 higher than 40 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI